Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.

Marzolini, C.; Kuritzkes, D.R.; Marra, F.; Boyle, A.; Gibbons, S.; Flexner, C.; Pozniak, A.; Boffito, M.; Waters, L.; Burger, D.; Back, D.; Khoo, S.

doi:10.7326/M22-0281

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.

Details

Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: Not specified

Serval ID

serval:BIB_70514994B951

Type

Article: article from journal or magazin.

Publication sub-type

Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.

Collection

Publications

Institution

UNIL/CHUV

Title

Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.

Journal

Annals of internal medicine

Author(s)

Marzolini C., Kuritzkes D.R., Marra F., Boyle A., Gibbons S., Flexner C., Pozniak A., Boffito M., Waters L., Burger D., Back D., Khoo S.

ISSN

1539-3704 (Electronic)

ISSN-L

0003-4819

Publication state

Published

Issued date

05/2022

Peer-reviewed

Oui

Volume

175

Number

Pages

744-746

Language

english

Notes

Publication types: Editorial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish

Abstract

Nirmatrelvir–ritonavir (NMV/r) is now being used to treat high-risk patients with mild to moderate COVID-19. This article provides advice to clinicians regarding recognition of medications likely to interact with NMV/r and suggests approaches to managing such drug–drug interactions. An algorithm is provided to assist in decision making.

Keywords

COVID-19, Drug Interactions, Humans, Ritonavir/therapeutic use, SARS-CoV-2

URN

urn:nbn:ch:serval-BIB_70514994B9518

OAI-PMH

oai:serval.unil.ch:BIB_70514994B951

DOI

10.7326/M22-0281

Pubmed

35226530

Web of science

000767336200001